Garcia-Parada Carlos 4
4 · ROCKET PHARMACEUTICALS, INC. · Filed Feb 16, 2022
Insider Transaction Report
Form 4
Garcia-Parada Carlos
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-14+54,006→ 54,006 totalExercise: $20.00Exp: 2032-02-13→ Common Stock (54,006 underlying) - Award
Restricted Stock Units
2022-02-14+17,322→ 17,322 total→ Common Stock (17,322 underlying)
Footnotes (3)
- [F1]This option represents a right to purchase a total of 54,006 shares of the Issuer's common stock, one-third (1/3) of which will become fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.